COVID-19 severe or critically | |
COVID-19 severe or critically | |
chloroquine and derivatives | Karolyi |
hydroxychloroquine | REMAP-CAP-HCQ HYDRA ... Sarhan Sarhan Mahevas Yu |
5226 | Duke university (Hydroxychloroquine), 2020 | 2 | 1 | 0 | excluded | risk of bias not avaialble | |
5864 | HYDRA, 2020 | 2 | 1 | 0 | excluded | risk of bias not avaialble |